Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic Fibrosis

NCT01401439 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2016-08-09

No results posted yet for this study

Summary

The purpose of this study is to find out whether measurement of body composition has a prognostic value on clinical and overall outcome in pediatric patients with cystic fibrosis.

Conditions

Sponsors & Collaborators

  • Arkansas Children's Hospital Research Institute

    collaborator OTHER
  • University of Arkansas

    lead OTHER

Principal Investigators

  • Ariel Berlinski, MD · University of Arkansas for Medical Sciences/Arkansas Children's Hospital

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01401439 on ClinicalTrials.gov